Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children

BACKGROUND: A recent randomized trial showed that artemisinin–naphthoquine (AN) was non-inferior to artemether–lumefantrine (AL) for falciparum malaria and superior for vivax malaria in young Papua New Guinean children. The aim of this study was to compare the cost-effectiveness of these two regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Brioni R., Davis, Wendy A., Clarke, Philip M., Robinson, Leanne J., Laman, Moses, Davis, Timothy M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663042/
https://www.ncbi.nlm.nih.gov/pubmed/29084540
http://dx.doi.org/10.1186/s12936-017-2081-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663042/
https://www.ncbi.nlm.nih.gov/pubmed/29084540
http://dx.doi.org/10.1186/s12936-017-2081-8

Ejemplares similares